AMED - Amedisys Non-GAAP EPS of $1.18 in-line revenue of $559.32M beats by $4.14M
Amedisys press release (NASDAQ:AMED): Q4 Non-GAAP EPS of $1.18 in-line. Revenue of $559.32M (+1.6% Y/Y) beats by $4.14M. For FY2022, the company expects adjusted diluted EPS in the range of $5.23 to $5.45 based on an estimated 33.2M shares outstanding vs. consensus of $5.84.
For further details see:
Amedisys Non-GAAP EPS of $1.18 in-line, revenue of $559.32M beats by $4.14M